The Escalating Price of Hope: Unpacking America’s Weight-Loss Drug Affordability Crisis
The arrival of highly effective weight-loss medications like Ozempic, Wegovy, and Mounjaro has been heralded as a turning point in the fight against obesity, a chronic disease affecting millions of Americans. These GLP-1 receptor agonists have demonstrated remarkable results, offering a tangible pathway to improved health and well-being. Yet, this medical advancement is increasingly overshadowed
The Escalating Price of Hope: Unpacking America’s Weight-Loss Drug Affordability Crisis Read More »